These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

904 related items for PubMed ID: 19516174

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
    Fossum E, Gleim GW, Kjeldsen SE, Kizer JR, Julius S, Devereux RB, Brady WE, Hille DA, Lyle PA, Dahlöf B.
    J Intern Med; 2007 Oct; 262(4):439-48. PubMed ID: 17875180
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Physical activity decreases the risk of stroke in middle-age men with left ventricular hypertrophy: 40-year follow-up (1961-2001) of the Seven Countries Study (the Corfu cohort).
    Pitsavos C, Panagiotakos DB, Chrysohoou C, Kokkinos P, Menotti A, Singh S, Dontas A, Seven Countries Study (the Corfu Cohort).
    J Hum Hypertens; 2004 Jul; 18(7):495-501. PubMed ID: 14985777
    [Abstract] [Full Text] [Related]

  • 28. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
    Blanchet Deverly A, Kangambega P, Hue K, Donnet JP, Merault H, Foucan L.
    Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
    [Abstract] [Full Text] [Related]

  • 29. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values.
    Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, Capra A, Giannattasio C, Dell'Oro R, Grassi G, Sega R, Mancia G.
    J Hypertens; 2009 Dec; 27(12):2458-64. PubMed ID: 19654559
    [Abstract] [Full Text] [Related]

  • 30. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z, Dahlöf B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, Nieminen MS, Jern S, Devereux RB.
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF, Cardoso CR, Muxfeldt ES.
    Arch Intern Med; 2008 Nov 24; 168(21):2340-6. PubMed ID: 19029499
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
    Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G.
    Nephrol Dial Transplant; 2004 Jul 24; 19(7):1829-34. PubMed ID: 15128888
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.